News

Filter

Current filters:

VelcadeGlaxoSmithKline

1 to 9 of 11 results

UK volume price plan for GSK's Tyverb

11-08-2008

The UK-based pharmaceutical major GlaxoSmithKline is allegedly considering the offer of a volume pricing…

AstraZenecabortezomibGlaxoSmithKlineGSKHerceptinLapatinibPfizerRochetrastuzumabTykerbVelcade

GlaxoSmithKline considers money-back deal with UK's NHS

18-06-2007

Following swiftly on last week's decision by Janssen-Cilag to offer a money-back guarantee for patients…

bortezomibGlaxoSmithKlineGSKJanssen-CilagVelcade

Millennium gets $40.0M milestones

14-03-2005

USA-based Millennium Pharmaceuticals says it will receive licensing fees and milestone payments of $40.0…

bortezomibEptifibatideGlaxoSmithKlineGSKIntegrilinJohnson & JohnsonVelcade

1 to 9 of 11 results

Back to top